Dioptra - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 128,404 | 128,981 | 101,207 | 91,033 | 158,360 | 163,517 | 161,787 | 189,468 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 17,094 | 7,654 | 3,659 | -7,652 | 33,640 | 21,551 | 4,552 | -25 |
| Equity | 27,661 | 35,315 | 35,050 | 27,398 | 61,038 | 82,588 | 87,140 | 87,115 |
| Liabilities | 61,514 | 55,329 | 47,120 | 47,679 | 52,115 | 31,139 | 31,774 | 27,678 |
| Non-current assets | 65,663 | 68,118 | 62,181 | 54,354 | 49,446 | 44,913 | 43,123 | 39,200 |
| Current assets | 18,197 | 14,198 | 17,200 | 16,213 | 34,632 | 47,116 | 63,875 | 66,419 |
| Total assets | 83,860 | 82,316 | 79,381 | 70,567 | 84,078 | 92,029 | 106,998 | 105,619 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 29,519 | 27,371 | 35,550 |
| Social insurance contributions | - | - | - | - | - | 8,923 | 16,870 | 20,891 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +29.9% | +0.4% | -21.5% | -10.1% | +74.0% | +3.3% | -1.1% | +17.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.4% | 9.3% | 4.6% | -10.8% | 40.0% | 23.4% | 4.3% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 61.8% | 21.7% | 10.4% | -27.9% | 55.1% | 26.1% | 5.2% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.3% | 5.9% | 3.6% | -8.4% | 21.2% | 13.2% | 2.8% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.2 | 1.6 | 1.3 | 1.7 | 0.9 | 0.4 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 32,101 | 32,245 | 25,302 | 22,758 | 41,312 | 39,244 | 27,735 | 27,067 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dioptra - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-02-19 | 2024-03-11 | 0.81 |
| 2022-11-21 | 2022-12-12 | 0.01 |
| 2022-11-17 | 2022-11-18 | 0.01 |
| 2022-08-23 | 2022-09-12 | 0.35 |
| 2022-07-25 | 2022-08-15 | 0.35 |
| 2022-05-17 | 2022-05-24 | 747.19 |
Dioptra - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dioptra, UAB (code 302664234) is a Private Limited Liability Company operating in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €189.5K, up 17.1% year on year and 15.9% over two years. Profitability weakened sharply: net profit was essentially breakeven at -€25, compared with €4.6K in 2024 and €21.6K in 2023, when the margin stood at 13.2% before falling to 2.8% in 2024 and to around zero in 2025. The balance sheet remained stable, with total assets of €105.6K, equity of €87.1K and liabilities of €27.7K at the end of 2025. Equity represented 82.5% of assets, and debt-to-equity was 0.32, indicating a conservative capital structure. Asset turnover was 1.79x, showing that the asset base continued to support sales efficiently. Revenue per employee was €27.1K, while profit per employee was -€4, reflecting the near-breakeven result in the latest financial year. Over the three-year period, revenue increased, but profitability declined materially.